EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leading U.S. biopharmaceutical company focused exclusively on specialty care.
For more than 40 years, EMD Serono has integrated cutting-edge science, innovative products and devices, and industry-leading patient support and
access programs. EMD Serono has deep expertise in neurology, fertility, and endocrinology, as well as a robust pipeline of potential therapies in neurology,
oncology, immunology, and immuno-oncology. Today, EMD Serono has more than 1,100 employees around the country with commercial, clinical, and research
operations based in the company's home state of Massachusetts.
For more information, please visit www.emdserono.com.